In rheumatoid arthritis (RA), the identification of prognostic factors (PF) capable of predicting disease outcome, response to treatment or success of dose reduction is an important issue, as these ...
Regulatory Approval/MiscellaneousFormycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases 27.09.2024 / 09:00 ...
Prevention of symptoms focuses on lifestyle changes and early, aggressive treatment through regular screenings with a rheumatologist ... Maintaining the body weight you and your healthcare provider ...